Maximize Your Impact At DxPx US 2026
DxPx US 2026, taking place on July 26 at the Anaheim Convention Center in Anaheim, California, brings together key decision-makers from diagnostics, digital health, personalized medicine, and life science tools. Known for fostering meaningful collaboration between startups, investors, and corporates, the event serves as a central meeting ground for professionals aiming to shape the future of precision health technologies.
The conference emphasizes deal-making, strategic investments, and partnership discussions. Many attending executives carry authority over purchasing decisions, R&D budgets, commercial partnerships, and innovation roadmaps. Startups and established firms alike use this event to establish new commercial pathways, validate strategic priorities, or formalize M&A conversations. With Vendelux’s enriched attendee list, teams can prioritize individuals with budget control, understand their investment interests, and craft messages that speak directly to their goals—well before the show floor opens.
How Sales, Marketing and Revops Teams Can Use This Attendee List
Sales, marketing, and revenue operations teams targeting healthtech, diagnostics, and biotech verticals can use the enriched conference attendee list to align outreach with commercial fit and strategic timing. For example, product teams selling lab automation solutions or digital diagnostics platforms can filter the attendee data by buyer role—such as clinical operations leads or heads of innovation—to focus on those evaluating tools for pipeline expansion.
Outreach can be validated against company types like startup, VC-funded, enterprise, or healthcare provider networks. With verified email addresses and LinkedIn profiles, teams can get more meetings on the calendar before the event and come prepared with tailored value propositions. For on-site engagement, the list helps prioritize individuals responsible for M&A, partnership development, or market expansion. Post-event, the data supports meaningful follow-up tied to what each prospect showed interest in during the conference.
Timing Is Everything
DxPx US 2026 is scheduled for July 26, 2026. To create traction at the event, outreach should begin well in advance of that date. Many attendees begin setting meetings and reviewing vendor materials weeks prior, making early engagement essential for visibility and momentum.
Vendelux clients gain access to enriched attendee data that can be segmented by seniority, company type, or strategic interest areas. Aligning this data with your sales and marketing cadences means you can time outreach to when your audience is most receptive—before their calendars fill. That initial connection can be the gateway to lasting business relationships if planned intentionally.
What’s Included In The DxPx US 2026 Attendee List?
Vendelux provides visibility into executives expected to attend DxPx US 2026 through a combination of organizer data and predictive models. Clients can upload a list of target accounts to identify attendee matches and prioritize outreach based on role, company focus, and strategic relevance.
The enriched attendee list includes first and last names, job titles, company names and websites, geographic location including city, state, and country, LinkedIn profiles, verified email addresses, and phone numbers when available.
Where Is DxPx US 2026?
The event will take place at the Anaheim Convention Center in Anaheim, California, United States.
When Is DxPx US 2026?
DxPx US 2026 is scheduled for July 26, 2026.
What Type Of Event Is DxPx US 2026?
DxPx US 2026 is a diagnostics and precision medicine industry event that connects investors, innovators, and commercial leaders for one-on-one partnering, strategic panels, and keynotes. The conference offers networking opportunities for companies seeking specialized knowledge, collaboration, or capital across healthtech and life sciences.
How Many People Attend DxPx US 2026?
The event is expected to attract over 350 attendees from more than 15 countries. The audience includes CEOs, decision-makers in diagnostics and digital health, early-stage healthtech founders, corporate development leads, and venture capitalists with a focus on precision medicine innovation.
